Cell transformation in tumor-development: a result of accumulation of Misrepairs of DNA through many generations of cells

Development of a tumor is known to be a result of accumulation of DNA changes in somatic cells. However, the processes of how DNA changes are produced and how they accumulate in somatic cells are not clear. DNA changes include two types: point DNA mutations and chromosome changes. However, point DNA mutations (DNA mutations) are the main type of DNA changes that can remain and accumulate in cells. Severe DNA injuries are the causes for DNA mutations. However, Misrepair of DNA is an essential process for transforming a DNA injury into a survivable and inheritable DNA mutation. In somatic cells, Misrepair of DNA is the main source of DNA mutations. Since the surviving chance of a cell by Misrepair of DNA is low, accumulation of DNA mutations can take place only possibly in the cells that can proliferate. Tumors can only develop in the tissues that are regenerable. The accumulation of Misrepairs of DNA needs to proceed in many generations of cells, and cell transformation from a normal cell into a tumor cell is a slow and long process. However, once a cell is transformed especially when it is malignantly transformed, the deficiency of DNA repair and the rapid cell proliferation will accelerate the accumulation of DNA mutations. The process of accumulation of DNA mutations is actually the process of aging of a genome DNA. Repeated cell injuries and repeated cell regenerations are the two preconditions for tumor-development. For cancer prevention, a moderate and flexible living style is advised.

💡 Research Summary

The paper proposes a unified framework for tumor development that centers on the accumulation of DNA point mutations generated through misrepair (Misrepair) of severe DNA damage across many cell generations. It begins by distinguishing two major categories of somatic DNA alterations: point mutations and chromosomal changes. While chromosomal alterations can have dramatic effects, the authors argue that they are less likely to persist because they often trigger cell death or are difficult to inherit. In contrast, point mutations are relatively subtle, can be tolerated by the cell, and therefore have the greatest potential to accumulate over time.

Severe DNA lesions—caused by external agents such as ionizing radiation, chemical carcinogens, or by endogenous reactive metabolites—overwhelm the high‑fidelity repair pathways. When accurate repair is impossible, a cell may resort to a rapid, error‑prone process that the authors term “Misrepair.” Misrepair reconnects broken DNA ends incorrectly, inserts or deletes nucleotides in an imprecise manner, and consequently fixes a mutation into the genome. Although this strategy enables the cell to survive an otherwise lethal injury, it also creates a heritable genetic change. The probability of a cell surviving via Misrepair is low, so only cells that retain proliferative capacity can propagate the mutation to subsequent generations.

Because of this requirement, the authors contend that tumors can arise only in tissues that possess regenerative potential—epithelial layers of the skin, gastrointestinal tract, hematopoietic system, and other continuously renewing compartments. In non‑regenerative tissues, cells rarely divide; thus, any mutation that does arise is unlikely to be transmitted to daughter cells. In regenerative tissues, however, each round of cell division provides an opportunity for a previously misrepaired DNA segment to be copied, and for additional misrepair events to occur in later generations. Over many cycles, point mutations accumulate, especially in genes that control cell proliferation (oncogenes) or genome stability (tumor‑suppressor genes such as TP53, RB1, APC).

The paper further describes a feedback loop that accelerates mutation accumulation once a cell has undergone malignant transformation. Malignant cells typically exhibit defective DNA‑damage response pathways, reducing the efficiency of accurate repair and increasing reliance on error‑prone mechanisms. Simultaneously, they proliferate at an accelerated rate, providing more replication cycles in which new errors can be introduced. This self‑reinforcing process is conceptualized as “genomic aging,” whereby the genome progressively accrues small lesions that collectively erode its integrity.

From a preventive standpoint, the authors argue that two preconditions are essential for cancer development: repeated cellular injury and repeated cellular regeneration. Accordingly, lifestyle interventions that minimize chronic exposure to DNA‑damaging agents (e.g., limiting ultraviolet radiation, avoiding tobacco carcinogens, reducing occupational chemical exposure) and that avoid excessive proliferative stimuli (e.g., over‑training, chronic inflammation) are advocated. They suggest that a “moderate and flexible” lifestyle—characterized by balanced nutrition, regular but not extreme physical activity, stress management, and periodic health monitoring—could reduce the frequency of Misrepair events and thereby lower cancer risk.

Therapeutically, the model implies that enhancing accurate DNA‑repair capacity (through pharmacologic activators of repair enzymes) or suppressing rapid cell cycling (using cell‑cycle inhibitors) could interrupt the cascade of Misrepair‑driven mutation accumulation. By targeting the underlying mechanism rather than individual downstream mutations, such strategies might provide broader protection against tumor initiation and progression.

In summary, the paper reframes tumorigenesis as a long‑term, multigenerational process driven primarily by error‑prone DNA repair in regenerative tissues. It integrates the concepts of DNA damage, misrepair, mutation fixation, and genomic aging into a coherent narrative, and it proposes both preventive lifestyle measures and potential therapeutic avenues aimed at reducing Misrepair frequency and enhancing genomic stability.